Cargando…

Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha

Specific treatments for the long-life infections by feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are either toxic, expensive or not too effective. Interferon α (IFN-α) is an immunomodulatory molecule which has been shown in vitro to decrease the release of infective particles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez-Lucia, Esperanza, Collado, Victorio M., Miró, Guadalupe, Martín, Sonsoles, Benítez, Laura, Doménech, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783854/ https://www.ncbi.nlm.nih.gov/pubmed/31514435 http://dx.doi.org/10.3390/v11090845

Ejemplares similares

Novel approach of dermatophytosis eradication in shelters: effect of Pythium oligandrum on Microsporum canis in FIV or FeLV positive cats
por: Načeradská, Martina, et al.
Publicado: (2021)

Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection
por: Hofmann-Lehmann, R., et al.
Publicado: (1995)

Acute monoblastic leukemia in a FeLV-positive cat
por: Prihirunkit, Kreangsak, et al.
Publicado: (2008)

Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection
por: Major, Andrea, et al.
Publicado: (2009)

Clinical and Hematological Follow-Up of Long-Term Oral Therapy with Type-I Interferon in Cats Naturally Infected with Feline Leukemia Virus or Feline Immunodeficiency Virus
por: Gomez-Lucia, Esperanza, et al.
Publicado: (2020)

Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats
por: Reinacher, M.
Publicado: (1989)

Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias
por: Abdollahi-Pirbazari, Mehdi, et al.
Publicado: (2019)

Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus
por: Almeras, T., et al.
Publicado: (2017)

Segregation of RD-114 and FeLV-related sequences in crosses between domestic cat and leopard cat
por: BENVENISTE, RAOUL E., et al.
Publicado: (1975)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia
por: Westman, Mark, et al.
Publicado: (2019)

High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings
por: Suntz, M., et al.
Publicado: (2010)

Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008–2019)
por: Pare, Amelie, et al.
Publicado: (2022)

Effect of Type-I Interferon on Retroviruses
por: Gómez-Lucía, Esperanza, et al.
Publicado: (2009)

Viral Determinants of FeLV Infection and Pathogenesis: Lessons Learned from Analysis of a Natural Cohort
por: Bolin, Lisa L., et al.
Publicado: (2011)

Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR
por: Finstad, Samantha L, et al.
Publicado: (2004)

Could Phylogenetic Analysis Be Used for Feline Leukemia Virus (FeLV) Classification?
por: Cano-Ortiz, Lucía, et al.
Publicado: (2022)

Molecular characterization of Brazilian FeLV strains in São Luis, Maranhão Brazil
por: Martins, Nathálya dos Santos, et al.
Publicado: (2023)

Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection
por: Wilson, Stephen, et al.
Publicado: (2012)

Use of recombinant interferon omega in feline retrovirosis: From theory to practice
por: Doménech, Ana, et al.
Publicado: (2011)

Development of antibodies to feline IFN-γ as tools to elucidate the cellular immune responses to FeLV
por: Graham, Elizabeth M., et al.
Publicado: (2003)

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
por: Ortiz, Raquel, et al.
Publicado: (2023)

Complete Genome Sequence of Feline Leukemia Virus Kawakami-Theilen Strain KT-FeLV-UCD-1
por: Chin, Pei-Ju, et al.
Publicado: (2020)

First description of a multisystemic and lethal SARS-CoV-2 variant of concern P.1 (Gamma) infection in a FeLV-positive cat
por: Carneiro, Rodrigo Lima, et al.
Publicado: (2022)

Evaluation of a Point-of-Care Feline Immunodeficiency Virus (FIV) Test Kit (RapidSTATUS™ FIV) to Determine the FIV Status of FIV-Vaccinated and FIV-Unvaccinated Pet Cats in Australia
por: Cheang, Ashley, et al.
Publicado: (2022)

Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component
por: Brunner, Chantal, et al.
Publicado: (2006)

Acute phase response to Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ infection in FIV-infected and non-FIV-infected cats
por: Korman, R.M., et al.
Publicado: (2012)

Enrichment Preferences of FIV-Infected and Uninfected Laboratory-Housed Cats
por: Kennedy, Claudia J., et al.
Publicado: (2018)

Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: Clinical and laboratory evaluation()
por: Gil, S., et al.
Publicado: (2014)

Feline T-cell lymphotropic lentivirus proteins; cat FIV virus used for the specific detection of FIV antibodies, production of antibodies and in vaccine; DNA sequence
Publicado: (1991)

Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)

Immunomodulator expression in trophoblasts from the feline immunodeficiency virus (FIV)-infected cat
por: Scott, Veronica L, et al.
Publicado: (2011)

Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax(®) FIV)
por: Westman, Mark, et al.
Publicado: (2021)

Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3
por: de Rozières, Sohela, et al.
Publicado: (2004)

Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV)
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Clinicopathological and Epidemiological Findings in Pet Cats Naturally Infected with Feline Immunodeficiency Virus (FIV) in Australia
por: Carlton, Caroline, et al.
Publicado: (2022)

Pathogenesis of oral FIV infection
por: Miller, Craig, et al.
Publicado: (2017)

Aberrant placental immune parameters in the feline immunodeficiency virus (FIV)-infected cat suggest virus-induced changes in T cell function
por: Chumbley, Lyndon Bart, et al.
Publicado: (2013)

Imbalance of placental regulatory T cell and Th17 cell population dynamics in the FIV-infected pregnant cat
por: Boudreaux, Crystal E, et al.
Publicado: (2012)

Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j303bs8r6t82pa89cba0jv09e0